CalciMedica Inc. (NASDAQ: CALC)
$3.7000
-1.1000 ( -22.90% ) 224.1K
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Market Data
Open
$3.7000
Previous close
$4.8000
Volume
224.1K
Market cap
$40.21M
Day range
$3.5300 - $4.0600
52 week range
$2.1400 - $8.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 25, 2024 |
8-k/a | 8K-related | 20 | Jan 24, 2024 |
8-k | 8K-related | 20 | Jan 22, 2024 |
4 | Insider transactions | 1 | Dec 13, 2023 |
8-k | 8K-related | 13 | Nov 09, 2023 |
10-q | Quarterly Reports | 58 | Nov 09, 2023 |
4 | Insider transactions | 1 | Nov 08, 2023 |
4 | Insider transactions | 1 | Nov 08, 2023 |
4 | Insider transactions | 1 | Nov 07, 2023 |
4 | Insider transactions | 1 | Nov 07, 2023 |